Search research articles
Contact Us
Filters
Showing results (1-10 of 479) with videos related to
Page
of 48
Sort By:
The Lancet. Respiratory Medicine
|
October 3, 2019
Pamrevlumab in idiopathic pulmonary fibrosis
Athol U Wells
Respirology (Carlton, Vic.)
|
June 19, 2019
Novel exploratory data in interstitial lung disease
Athol U Wells
American Journal of Respiratory and Critical Care Medicine
|
October 12, 2004
Histopathologic diagnosis in diffuse lung disease: an ailing gold standard
Athol U Wells
Respirology (Carlton, Vic.)
|
March 27, 2024
Optimal clinical practice in IPF and PPF: Integrating the scientific ethos and clinical reasoning
Athol U Wells
BMC Medicine
|
February 11, 2016
"Any fool can make a rule and any fool will mind it"
Athol U Wells
The Lancet. Respiratory Medicine
|
September 19, 2018
IPF diagnosis: flexibility is a virtue
Athol U Wells
Seminars in Respiratory and Critical Care Medicine
|
September 4, 2007
Pulmonary function tests in connective tissue disease
Athol U Wells
Seminars in Respiratory and Critical Care Medicine
|
August 10, 2005
High-resolution computed tomography in the diagnosis of diffuse lung disease: a clinical perspective
Athol U Wells
Annals of the American Thoracic Society
|
June 1, 2022
Analyses of the Efficacy and Safety of Antifibrotic Therapies in Non-IPF Pulmonary Fibrosis, Progressing Despite Management
Athol U Wells
The Lancet. Respiratory Medicine
|
January 17, 2014
Chronic hypersensitivity pneumonitis in the setting of definite IPF: does the current study undermine IPF guideline recommendations?
Athol U Wells
Page
of 48
Search research articles
Search
Showing results (1-10 of 479) with videos related to
Sort By:
Page
of 48
The Lancet. Respiratory Medicine
|
October 3, 2019
Pamrevlumab in idiopathic pulmonary fibrosis
Athol U Wells
Respirology (Carlton, Vic.)
|
June 19, 2019
Novel exploratory data in interstitial lung disease
Athol U Wells
American Journal of Respiratory and Critical Care Medicine
|
October 12, 2004
Histopathologic diagnosis in diffuse lung disease: an ailing gold standard
Athol U Wells
Respirology (Carlton, Vic.)
|
March 27, 2024
Optimal clinical practice in IPF and PPF: Integrating the scientific ethos and clinical reasoning
Athol U Wells
BMC Medicine
|
February 11, 2016
"Any fool can make a rule and any fool will mind it"
Athol U Wells
The Lancet. Respiratory Medicine
|
September 19, 2018
IPF diagnosis: flexibility is a virtue
Athol U Wells
Seminars in Respiratory and Critical Care Medicine
|
September 4, 2007
Pulmonary function tests in connective tissue disease
Athol U Wells
Seminars in Respiratory and Critical Care Medicine
|
August 10, 2005
High-resolution computed tomography in the diagnosis of diffuse lung disease: a clinical perspective
Athol U Wells
Annals of the American Thoracic Society
|
June 1, 2022
Analyses of the Efficacy and Safety of Antifibrotic Therapies in Non-IPF Pulmonary Fibrosis, Progressing Despite Management
Athol U Wells
The Lancet. Respiratory Medicine
|
January 17, 2014
Chronic hypersensitivity pneumonitis in the setting of definite IPF: does the current study undermine IPF guideline recommendations?
Athol U Wells
Page
of 48